N-[2-[[6-(4-chlorophenyl)-4-[2-(ethylamino)-2-oxoethyl]-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-8-yl]oxy]ethyl]-4-[[hydroxy(dimethyl)silyl]methyl]benzamide

C33H37ClN6O4Si — CID 123502709

IUPACN-[2-[[6-(4-chlorophenyl)-4-[2-(ethylamino)-2-oxoethyl]-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-8-yl]oxy]ethyl]-4-[[hydroxy(dimethyl)silyl]methyl]benzamide
SMILESCCNC(=O)CC1N=C(c2ccc(Cl)cc2)c2cc(OCCNC(=O)c3ccc(C[Si](C)(C)O)cc3)ccc2-n2c(C)nnc21
InChIInChI=1S/C33H37ClN6O4Si/c1-5-35-30(41)19-28-32-39-38-21(2)40(32)29-15-14-26(18-27(29)31(37-28)23-10-12-25(34)13-11-23)44-17-16-36-33(42)24-8-6-22(7-9-24)20-45(3,4)43/h6-15,18,28,43H,5,16-17,19-20H2,1-4H3,(H,35,41)(H,36,42)
InChIKeyGRNKHYKCNJIFFG-UHFFFAOYSA-N
MW645.24 g/mol
LogP4.74
Rot. Bonds11

About N-[2-[[6-(4-chlorophenyl)-4-[2-(ethylamino)-2-oxoethyl]-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-8-yl]oxy]ethyl]-4-[[hydroxy(dimethyl)silyl]methyl]benzamide

N-[2-[[6-(4-chlorophenyl)-4-[2-(ethylamino)-2-oxoethyl]-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-8-yl]oxy]ethyl]-4-[[hydroxy(dimethyl)silyl]methyl]benzamide (PubChem CID 123502709) has the molecular formula C33H37ClN6O4Si and a molecular weight of 645.24 g/mol. Its IUPAC name is N-[2-[[6-(4-chlorophenyl)-4-[2-(ethylamino)-2-oxoethyl]-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-8-yl]oxy]ethyl]-4-[[hydroxy(dimethyl)silyl]methyl]benzamide.

Molecular Properties

Compound NameN-[2-[[6-(4-chlorophenyl)-4-[2-(ethylamino)-2-oxoethyl]-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-8-yl]oxy]ethyl]-4-[[hydroxy(dimethyl)silyl]methyl]benzamide
PubChem CID123502709
Molecular FormulaC33H37ClN6O4Si
Molecular Weight645.24 g/mol
Exact Mass644.23
IUPAC NameN-[2-[[6-(4-chlorophenyl)-4-[2-(ethylamino)-2-oxoethyl]-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-8-yl]oxy]ethyl]-4-[[hydroxy(dimethyl)silyl]methyl]benzamide
SMILESCCNC(=O)CC1N=C(c2ccc(Cl)cc2)c2cc(OCCNC(=O)c3ccc(C[Si](C)(C)O)cc3)ccc2-n2c(C)nnc21
InChIInChI=1S/C33H37ClN6O4Si/c1-5-35-30(41)19-28-32-39-38-21(2)40(32)29-15-14-26(18-27(29)31(37-28)23-10-12-25(34)13-11-23)44-17-16-36-33(42)24-8-6-22(7-9-24)20-45(3,4)43/h6-15,18,28,43H,5,16-17,19-20H2,1-4H3,(H,35,41)(H,36,42)
InChIKeyGRNKHYKCNJIFFG-UHFFFAOYSA-N
XLogP4.74
TPSA130.73 Ų
H-Bond Donors3
H-Bond Acceptors8
Rotatable Bonds11
Heavy Atoms45
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500645.24
LogP ≤ 54.74
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 108

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'heavy_metal', 'substructure': 'N/A'}

Analyze N-[2-[[6-(4-chlorophenyl)-4-[2-(ethylamino)-2-oxoethyl]-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-8-yl]oxy]ethyl]-4-[[hydroxy(dimethyl)silyl]methyl]benzamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[2-[[6-(4-chlorophenyl)-4-[2-(ethylamino)-2-oxoethyl]-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-8-yl]oxy]ethyl]-4-[[hydroxy(dimethyl)silyl]methyl]benzamide?
The IUPAC name of N-[2-[[6-(4-chlorophenyl)-4-[2-(ethylamino)-2-oxoethyl]-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-8-yl]oxy]ethyl]-4-[[hydroxy(dimethyl)silyl]methyl]benzamide (CID 123502709) is N-[2-[[6-(4-chlorophenyl)-4-[2-(ethylamino)-2-oxoethyl]-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-8-yl]oxy]ethyl]-4-[[hydroxy(dimethyl)silyl]methyl]benzamide.
What is the SMILES notation for N-[2-[[6-(4-chlorophenyl)-4-[2-(ethylamino)-2-oxoethyl]-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-8-yl]oxy]ethyl]-4-[[hydroxy(dimethyl)silyl]methyl]benzamide?
The canonical SMILES for N-[2-[[6-(4-chlorophenyl)-4-[2-(ethylamino)-2-oxoethyl]-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-8-yl]oxy]ethyl]-4-[[hydroxy(dimethyl)silyl]methyl]benzamide is CCNC(=O)CC1N=C(c2ccc(Cl)cc2)c2cc(OCCNC(=O)c3ccc(C[Si](C)(C)O)cc3)ccc2-n2c(C)nnc21.
What is the InChIKey of N-[2-[[6-(4-chlorophenyl)-4-[2-(ethylamino)-2-oxoethyl]-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-8-yl]oxy]ethyl]-4-[[hydroxy(dimethyl)silyl]methyl]benzamide?
The InChIKey is GRNKHYKCNJIFFG-UHFFFAOYSA-N. The full InChI is InChI=1S/C33H37ClN6O4Si/c1-5-35-30(41)19-28-32-39-38-21(2)40(32)29-15-14-26(18-27(29)31(37-28)23-10-12-25(34)13-11-23)44-17-16-36-33(42)24-8-6-22(7-9-24)20-45(3,4)43/h6-15,18,28,43H,5,16-17,19-20H2,1-4H3,(H,35,41)(H,36,42).
What are the key properties of N-[2-[[6-(4-chlorophenyl)-4-[2-(ethylamino)-2-oxoethyl]-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-8-yl]oxy]ethyl]-4-[[hydroxy(dimethyl)silyl]methyl]benzamide?
N-[2-[[6-(4-chlorophenyl)-4-[2-(ethylamino)-2-oxoethyl]-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-8-yl]oxy]ethyl]-4-[[hydroxy(dimethyl)silyl]methyl]benzamide has a molecular weight of 645.24 g/mol, XLogP of 4.74, 11 rotatable bonds, 3 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for N-[2-[[6-(4-chlorophenyl)-4-[2-(ethylamino)-2-oxoethyl]-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-8-yl]oxy]ethyl]-4-[[hydroxy(dimethyl)silyl]methyl]benzamide is sourced from PubChem (CID 123502709), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).